ArticleFrontiers in oncology2026
A denoising autoencoder-enhanced ResNet 50 framework for explainable brain tumor classification using MRI.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors are a major issue in neurological health where the timely and accurate diagnosis is critical in the effectiveness of the clinical intervention and the outcome of the patients. It is believed that magnetic resonance imaging (MRI) is the imaging modality that is predominantly used to evaluate brain tumors due to the fact that it has excellent soft-tissue contrast, however, the analysis of automated MRI is hindered by noise, inhomogeneity in intensities, inter-scanner variation, and even the visual similarity that is exhibited by different tumor subtypes. In order to overcome these challenges, the current research presents a powerful, understandable deep learning architecture to be used in the context of multi-classification of brain tumors using MRI scans. The proposed methodology is a denoising autoencoder (DAE) based image improvement step with a transfer-learning based ResNet-50 classifier. The DAE is trained without any supervision to suppress noise and emphasize salient anatomical structures before classification. The improved images then undergo refinement of a pretrained ResNet-50 network to label MRI scans with four clinically relevant classes. The experimental assessment of a publicly available benchmark dataset shows that the framework has a test accuracy of 98.93% and the precision, recall, and F1-scores are high in all classes. Furthermore, the gradient mapping technique (Grad-CAM) is used to provide visual explainability of the model predictions by highlighting image regions that influence the classification outcomes. These results show the potential of the proposed framework as an explainable AI-assisted decision-support approach for brain tumor MRI classification. Further validation using external and multi-center clinical datasets is required before clinical deployment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.